Sample size recalculation in multicenter randomized controlled clinical trials based on noncomparative data.

Biometrical Journal. Biometrische Zeitschrift
Markus Harden, Tim Friede

Abstract

Many late-phase clinical trials recruit subjects at multiple study sites. This introduces a hierarchical structure into the data that can result in a power-loss compared to a more homogeneous single-center trial. Building on a recently proposed approach to sample size determination, we suggest a sample size recalculation procedure for multicenter trials with continuous endpoints. The procedure estimates nuisance parameters at interim from noncomparative data and recalculates the sample size required based on these estimates. In contrast to other sample size calculation methods for multicenter trials, our approach assumes a mixed effects model and does not rely on balanced data within centers. It is therefore advantageous, especially for sample size recalculation at interim. We illustrate the proposed methodology by a study evaluating a diabetes management system. Monte Carlo simulations are carried out to evaluate operation characteristics of the sample size recalculation procedure using comparative as well as noncomparative data, assessing their dependence on parameters such as between-center heterogeneity, residual variance of observations, treatment effect size and number of centers. We compare two different estimators for b...Continue Reading

References

Jan 1, 1990·Statistics in Medicine·J Wittes, E Brittain
Jun 11, 1999·Statistics in Medicine·C S Coffey, K E Muller
Jul 17, 1999·Statistics in Medicine·J S Denne, C Jennison
Dec 28, 1999·Statistics in Medicine·D M ZuckerE Brittain
Jan 10, 2002·Statistics in Medicine·T Friede, M Kieser
Dec 4, 2003·Statistics in Medicine·Meinhard Kieser, Tim Friede
Apr 2, 2005·Statistics in Medicine·Biao Xing, Jitendra Ganju
Sep 16, 2006·Biometrical Journal. Biometrische Zeitschrift·Tim Friede, Meinhard Kieser
Apr 10, 2009·Biometrical Journal. Biometrische Zeitschrift·Michael A Proschan
Jun 23, 2009·BMC Medical Research Methodology·Emilie Vierron, Bruno Giraudeau
Jul 8, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Anne HolbrookUNKNOWN COMPETE II Investigators
Apr 16, 2010·Biometrical Journal. Biometrische Zeitschrift·Katrin Jensen, Meinhard Kieser
Mar 20, 2012·Statistical Methods in Medical Research·Atanu Biswas, Rahul Bhattacharya
Aug 4, 2018·Biometrical Journal. Biometrische Zeitschrift·Michael J GraylingJames M S Wason
Aug 4, 2018·Biometrical Journal. Biometrische Zeitschrift·Michael J GraylingJames M S Wason
Dec 1, 2018·BMC Medical Research Methodology·Markus Harden, Tim Friede

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.